Minghao H. Wang - Publications

Super-enhancer-hijacking RBBP7 potentiates metastasis and stemness of breast cancer via recruiting NuRD complex subunit LSD1.

Journal: Journal of translational medicine

Published: August 22, 2024

Experience with the safe admission of breast and thyroid cancer patients in non-endemic areas during an epidemic outbreak.

Journal: Frontiers in oncology

Published: May 10, 2023

A multicenter single-arm trial of neoadjuvant pyrotinib and trastuzumab plus chemotherapy for HER2-positive breast cancer.

Journal: MedComm

Published: April 10, 2023

A multi-center cross-sectional investigation of the diagnosis and treatment of breast cancer with synchronous ipsilateral supraclavicular lymph node metastases based on the CSBrs-009.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: September 11, 2022

A novel twelve-gene signature to predict neoadjuvant chemotherapy response and prognosis in breast cancer.

Journal: Frontiers in immunology

Published: September 03, 2022

PIK3CA mutations are associated with pathologic complete response rate to neoadjuvant pyrotinib and trastuzumab plus chemotherapy for HER2-positive breast cancer.

Journal: British journal of cancer

Published: May 06, 2022

Neoadjuvant Pyrotinib plus Trastuzumab and Chemotherapy for Stage I-III HER2-Positive Breast Cancer: A Phase II Clinical Trial.

Journal: The oncologist

Published: September 07, 2020

Supraclavicular lymph node dissection with radiotherapy versus radiotherapy alone for operable breast cancer with synchronous ipsilateral supraclavicular lymph node metastases: a real-world cohort study.

Journal: Gland surgery

Published: May 19, 2020

Prognostic Value of Lymph Node Ratio in Breast Cancer Patients with Adequate Pathologic Evidence After Neoadjuvant Chemotherapy.

Journal: Medical science monitor : international medical journal of experimental and clinical research

Published: April 30, 2020

A clinical study on the use of Huaier granules in post-surgical treatment of triple-negative breast cancer.

Journal: Gland surgery

Published: February 12, 2020

Huaier polysaccharide inhibits the stem-like characteristics of ERα-36high triple negative breast cancer cells via inactivation of the ERα-36 signaling pathway.

Journal: International journal of biological sciences

Published: May 19, 2018

Germline mutations in 40 cancer susceptibility genes among Chinese patients with high hereditary risk breast cancer.

Journal: International journal of cancer

Published: November 08, 2017